Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: Effects of non-uniform attenuation correction on lesion detection

European Journal of Nuclear Medicine

Volumn 26, Issue 8, 1999, Pages 818-823

  Zimny, M ^a   Kaiser, H J ^a   Cremerius, U ^a   Reinartz, P ^a   Schreckenberger, M ^a   Sabri, O ^a   Buell, U ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Attenuation correction; Dual head gamma camera; Oncological patients; Positron emission tomography

Indexed keywords

CESIUM; FLUORODEOXYGLUCOSE F 18; GERMANIUM;

ADULT; AGED; ARTICLE; ATTENUATION; CANCER; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EVALUATION STUDIES; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GAMMA CAMERAS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED; NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032765067     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050454     Document Type: Article

References (25)

1. 1. Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, Benoit T, Foidart-Willems J. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996; 23: 1641-1674.
2. 2. Conti PS, Keppler JS, Halls JM. Positron emission tomography: a financial and operational analysis. Am J Roentgenol 1994; 162: 1279-1286.
3. 3. Drane WE, Abbott FD, Nicole MW, Mastin ST, Kuperus JH. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress. Radiology 1994; 191: 461-465.
4. 4. Holle LH, Trampert L, Lung-Kurt S, Villena-Heinsen CE, Puschel W, Schmidt S, Oberhausen E. Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT. J Nucl Med 1996; 37: 615-622.
5. 5. Macfarlane DJ, Cotton L, Ackermann RJ, Minn H, Ficaro EP, Shreve PD, Wahl RL. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET. Radiology 1995; 194: 425-429.
6. 6. Martin WH, Delbeke D, Patton JA, Hendrix B, Weinfeld Z, Ohana I, Kessler RM, Sandler MP. FDG-SPECT: correlation with FDG-PET. J Nucl Med 1995; 36: 988-995.
7. 7. Martin WH, Delbeke D, Patton JA, Sandler MP. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose. Radiology 1996; 198: 225-231.
8. 8. Mukherji SK, Drane WE, Mancuso AA, Parsons JT, Mendenhall WM, Stringer S. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT. Radiology 1996; 199: 761-766.
9. 18F-fluorodeoxyglucose single-photon emission computed tomography. Am J Roentgenol 1997; 168: 771-774.
10. 18FDG in the primary staging of lung tumors. Results with a gamma camera and a 511 keV collimator. Nuklearmedizin 1995; 34: 79-86.
11. 11. Lonneux M, Delval D, Bausart R, Moens R, Willockx R, Mael PV, Declerck P, Jamar F, Zreik H, Pauwels S. Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer. Nucl Med Commun 1998; 19: 1047-1054.
12. 12. Shreve PD, Steventon RS, Deters EC, Kison PV, Gross MD, Wahl RL. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology 1998; 207: 431-437.
13. 13. Schwaiger M, Ziegler S. PET using a coincidence camera versus ring tomography, progress or recession? [editorial]. Nuklearmedizin 1997; 36: 3-5.
14. 14. Delbeke D, Patton JA, Martin WH, Sandler MP. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders. J Nucl Med 1999; 40: 110-117.
15. 15. Zimny M, Kaiser HJ, Cremerius U, Sabri O, Schreckenberger M, Reinartz P, Buell U. Fluorine-18-fluorodeoxyglucose positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET. Nuklearmedizin 1999; 38: 108-114.
16. 16. Stokkel MP, Terhaard CH, Mertens IJ, Hordijk GJ, van Rijk PP. Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging. J Nucl Med 1998; 39: 1385-1387.
17. 137Cs source. Phys Med Biol 1995; 40: 929-944.
18. 137Cs. Phys Med Biol 1995; 40: 1255-1266.
19. 19. Shao L, Nellemann P, Muehllehner G, Bertelsen H, Hines H. Singles-transmission attenuation correction for dual head coincidence imaging. J Nucl Med (Suppl) 1998; 39: 37P.
20. 20. Shepp LA, Vardi Y. Maximum likelihood reconstruction for positron emission tomography. IEEE Trans Med Imaging 1982; 2: 113-122.
21. 21. Lewellen TK, Miyaoka RS, Swan WL. PET imaging using dual-headed gamma cameras: an update. Nucl Med Commun 1999; 20: 5-12.
22. 22. Thill R, Neuerburg J, Fabry U, Cremerius U, Wagenknecht G, Hellwig D, Osieka R, Gunther R, Bull U. Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma (in German). Nuklearmedizin 1997; 36: 234-239.
23. 23. Kotzerke J, Guhlmann A, Moog F, Frickhofen N, Reske SN. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med 1999; 26: 31-38.
24. 24. Bengel FM, Ziegler SI, Avril N, Weber W, Laubenbacher C, Schwaiger M. Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med 1997; 24: 1091-1098.
25. 25. Zasadny KR, Kison PV, Quint LE, Wahl RL. Untreated lung cancer: quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans. Radiology 1996; 201: 873-876.